Avocent Belgium Limited SRL
Avocent Belgium Limited reported total assets of 204,654 € at the end of the 2024 financial year (annual accounts filed with the NBB on 23 Oct 2025).
The score of Avocent Belgium Limited shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Avocent Belgium Limited's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 23 Oct 2025
- Year ended 31 Dec 2023filed on 05 Dec 2024
- Year ended 31 Dec 2022filed on 24 Nov 2023
- Year ended 31 Dec 2021filed on 24 Jan 2023
Avocent Belgium Limited's financial analysis
- Solvency-91.7%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Avocent Belgium Limited
Avocent Belgium Limited's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0890.423.970
- VAT number
- BE0890423970
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 28 Jun 2007
- Registered office
- 1000 Brussels
- Latest accounts
- 2024 · filed on 28 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Avocent Belgium Limited (SRL) has been based in Brussels since 2007, active in: activities of holding companies. For 2024, it reports a net loss of 84,611 € and equity of −187,744 €; its revenue is not published. Its solvency stands at -91.7%, below the median of its sector (60.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Avocent Belgium Limited
Companies in the same business, of comparable size and area, outside its group.
- Medi KTM General medical practice activities Brussels · balance sheet 204,611 €
- Svening Activities of holding companies Bornem · balance sheet 204,805 €
- ARVascu Medical specialists activities Charleroi · balance sheet 204,930 €
- Remwaal De Haan · balance sheet 204,932 €
- Detente et Musique Rental and operating of own or leased real estate Uccle · balance sheet 204,368 €
- PPO General Partner Activities of money market and non-money market investments funds Roeselare · balance sheet 204,999 €
- KEO Motion picture, video and television programme production activities Ixelles · balance sheet 203,023 €
- Locht Immo Group Other business support service activities n.e.c. Pelt · balance sheet 204,249 €
Frequently asked questions about Avocent Belgium Limited
What is the revenue of Avocent Belgium Limited?
Avocent Belgium Limited files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Avocent Belgium Limited?
In Belgium, the VAT number is the company number prefixed with BE: BE0890423970 for Avocent Belgium Limited, if the company is VAT-registered. Its company number (CBE) is 0890.423.970.
Where is the registered office of Avocent Belgium Limited?
According to the CBE register, the registered office of Avocent Belgium Limited is in 1000 Brussels.
What is the equity of Avocent Belgium Limited?
At the close of the 2024 financial year, the equity of Avocent Belgium Limited amounts to -187,744 €, a solvency of -91.7% of total assets.
Who manages Avocent Belgium Limited?
The register lists 5 active mandates at Avocent Belgium Limited. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Avocent Belgium Limited
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →